Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K + channels in rat hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 5, 2006, Pages

  Dang, Van Cuong ^a   Kim, Nari ^a   Jae, Boum Youm ^a   Joo, Hyun ^a   Warda, Mohamad ^a   Lee, Jae Wha ^b   Won, Sun Park ^a   Kim, Taeho ^a   Kang, Sunghyun ^a   Kim, Hyungkyu ^a   Han, Jin ^a  

^a Inje University   (South Korea)

^b Silla University   (South Korea)

Author keywords

Adenosine 5 triphosphate; Guanosine 3 ,5 cyclic monophosphate; Oxidative damage

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BETA PHENYL 1,N 2 ETHENO 8 BROMOGUANOSINE 3',5' CYCLICMONOPHOSPHORITHIOATE; CYCLIC GMP DEPENDENT PROTEIN KINASE; DIAZOXIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; PHOSPHOROTHIOIC ACID DERIVATIVE; PINACIDIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANOXIA; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DNA STRAND BREAKAGE; ENZYME RELEASE; HEART INJURY; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOLEMMA; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ISCHEMIC PRECONDITIONING; MALE; MYOCYTES, CARDIAC; NITRIC OXIDE; OXIDATIVE STRESS; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 33646392453     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00772.2005     Document Type: Article

References (62)

1. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, and Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416: 337-339, 2002.
2. Beckman JS and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol Cell Physiol 271: C1424-C1437, 1996.
3. Bekheit SS, Restivo M, Boutjdir M, Henkin R, Gooyandeh K, Assadi M, Khatib S, Gough WB, and el-Sherif N. Effects of glyburide on ischemia-induced changes in extracellular potassium and local myocardial activation: a potential new approach to the management of ischemiainduced malignant ventricular arrhythmias. Am Heart J 119: 1025-1033, 1990.
4. Bertuglia S and Giusti A. Microvascular oxygenation, oxidative stress, NO suppression and superoxide dismutase during postischemic reperfusion. Am J Physiol Heart Circ Physiol 285: H1064-H1071, 2003.
5. Bolli R. Postischemic myocardial "stunning": pathogenesis, pathophysiology and clinical relevance. In: Myocardial Protection: The Pathophysiology of Reperfusion and Reperfusion Injury, edited by Yellon DM and Jennings RB. New York: Raven, 1992, p. 607-622.
6. Buchwalow IB, Schulze W, Karczewski P, Kostic MM, Wallukat G, Morwinski R, Krause EG, Muller J, Paul M, Slezak J, Luft FC, and Haller H. Inducible nitric oxide synthase in the myocard. Mol Cell Biochem 217: 73-82, 2001.
7. Busija DW, Katakam P, Rajapakse NC, Kis B, Grover G, Domoki F, and Bari F. Effects of ATP-sensitive potassium channel activators diazoxide and BMS-191095 on membrane potential and reactive oxygen species production in isolated piglet mitochondria. Brain Res Bull 30: 85-90, 2005.
8. ATP channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovasc Res 51: 691-700, 2001.
9. Collins AR and Dusinska M. Oxidation of cellular DNA measured with the comet assay. In: Oxidative Stress Biomarkers and Antioxidant Protocols, edited by Armstrong D. Totowa, NJ: Humana, 2002, p. 147-159.
10. Collins A, Dusinska M, Franklin M, Somorovska M, Petrovska H, Duthie S, Fillion L, Panayiotidis M, Raslova K, and Vaughan N. Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mutagen 30: 139-146, 1997.
11. Crompton M, Virji S, Doyle V, Johnson N, and Ward JM. The mitochondrial permeability transition pore. Biochem Soc Symp 66: 167-179, 1999.
12. Csonka C, Szilvassy Z, Fulop F, Pali T, Blasig IE, Tosaki A, Schulz R, and Ferdinandy P. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation 100: 2260-2266, 1999.
13. + channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 283: H284-H295, 2002.
14. + channels in cardiac muscle by the sulphonylurea drug glibenclamide. J Pharmacol Exp Ther 261: 540-545, 1992.
15. Fryer RM, Patel HH, Hsu AK, and Gross GJ. Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am J Physiol Heart Circ Physiol 281: H1184-H1192, 2001.
16. + channels. Possible mechanism of cardioprotection. Circ Res 81: 1072-1082, 1997.
17. Gasser RN and Vaughan-Jones RD. Mechanism of potassium efflux and action potential shortening during ischaemia in isolated mammalian cardiac muscle. J Physiol 431: 713-741, 1990.
18. Giovannelli L, Cozzi A, Guarnieri I, Dolara P, and Moroni F. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly-(ADP-ribose) polymerase inhibitors. J Cereb Blood Flow Metab 22: 697-704, 2002.
19. Gross GJ. Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 35: 709-718, 2003.
20. ATP channels in the antiarrhythmic effects of ischaemic preconditioning in dogs. Br J Pharmacol 137: 939-940, 2002.
21. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y, and Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 96: 11507-11512, 1999.
22. + channel current in atrial myocytes of guinea pig heart. Jpn J Pharmacol 54: 473-477, 1990.
23. Han J, Kim C, Kim N, Park J, Yang Y, and Kim E. The protective effect of melatonin administration against adriamycin-induced cardiotoxicity in rats. Kor J Physiol Pharmacol 5: 333-342, 2001.
24. Han J, Kim E, Ho WK, and Earm YE. Blockade of the ATP-sensitive potassium channel by taurine in rabbit ventricular myocytes. J Mol Cell Cardiol 28: 2043-2050, 1996.
25. + channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 283: H1545-H1554, 2002.
26. Han J, Kim N, Kim E, Ho WK, and Earm YE. Modulation of ATP-sensitive potassium channel by cGMP-dependent protein kinase in rabbit ventricular myocytes. J Biol Chem 276: 22140-22147, 2001.
27. ATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 542: 735-741, 2002.
28. Hausenloy DJ, Duchen MR, and Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 60: 617-625, 2003.
29. ATP channels. Mol Pharmacol 55: 1000-1005, 1999.
30. Ichinose M, Yonemochi H, Sato T, and Saikawa T. Diazoxide triggers cardioprotection against apoptosis induced by oxidative stress. Am J Physiol Heart Circ Physiol 284: H2235-H2241, 2003.
31. Jirsova K, Mandys V, Gispen WH, and Bar PR. Cisplatin-induced apoptosis in cultures of human Schwann cells. Neurosci Lett 392: 22-26, 2006.
32. Kevelaitis E, Peynet J, Mouas C, Launay JM, and Menasche P. Opening of potassium channels: the common cardioprotective link between preconditioning and natural hibernation? Circulation 99: 3079-3085, 1999.
33. Kiechle FL and Malinski T Nitric oxide biochemistry, pathophysiology and detection. Am J Clin Pathol 100: 567-575, 1993.
34. 1 receptor activation. Am J Physiol Heart Circ Physiol 272: H325-H333, 1997.
35. Lefer DJ and Granger DN. Oxidative stress and cardiac disease. Am J Med 109: 315-323, 2000.
36. Liu Y, Sato T, O'Rourke B, and Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97: 2463-2469, 1998.
37. Loke KE, McConnell PI, Tuzman JM, Shesely EG, Smith CJ, Stackpole CJ, Thompson CI, Kaley G, Wolin MS, and Hintze TH. Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res 84: 840-845, 1999.
38. Maejima Y, Adachi S, Ito H, Nobori K, Tamamori-Adachi M, and Isobe M. Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity. Cardiovasc Res 59: 308-320, 2003.
39. McKelvey-Martin VJ, Green MH, Schmezer P, Pool-Zobel BL, De Meo MP, and Collins A. The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 288: 47-63, 1993.
40. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
41. Moncada S and Erusalimsky JD. Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat Rev Mol Cell Biol 3: 214-220, 2002.
42. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
43. Nasr-Esfahani MH, Salehi M, Razavi S, Anjomshoa M, Rozbahani S, Moulavi F, and Mardani M. Effect of sperm DNA damage and sperm protamine deficiency on fertilization and embryo development post-ICSI. Reprod Biomed Online 11: 198-205, 2005.
44. ATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 286: H468-H763, 2004.
45. Patten RD, Denofrio D, El-Zaru M, Kakkar R, Saunders J, Celestin F, Warner K, Rastegar H, Khabbaz KR, Udelson JE, Konstam MA, and Karas RH. Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart. J Am Coll Cardiol 45: 1419-1424, 2005.
46. ATP channels and myocardial ischemic preconditioning. J Cell Mol Med 6: 453-464, 2002.
47. Radi R, Rodriguez M, Castro L, and Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308: 89-95, 1994.
48. Sam F, Sawyer DB, Xie Z, Chang DL, Ngoy S, Brenner DA, Siwik DA, Singh K, Apstein CS, and Colucci WS. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res 89: 351-356, 2001.
49. Sasaki N, Sato T, Ohler A, O'Rourke B, and Marban E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101: 439-445, 2000.
50. + channels by protein kinase C. Circ Res 83: 110-114, 1998.
51. Singh NP, McCoy MT, Tice RR, and Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175: 184-191, 1988.
52. Southam E and Garthwaite J. Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices. Neurosci Lett 130: 107-111, 1991.
53. Supiot S, Gouard S, Charrier J, Apostolidis C, Chatal JF, Barbet J, Davodeau F, and Cherel M. Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines. Clin Cancer Res 11: S7047-S7052, 2005.
54. Taimor G, Hofstaetter B, and Piper HM. Apoptosis induction by nitric oxide in adult cardiomyocytes via cGMP-signaling and its impairment after simulated ischemia. Cardiovasc Res 45: 588-594, 2000.
55. Vegh A, Szekeres L, and Parratt J. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 107: 648-652, 1992.
56. + loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ Res 69: 623-637, 1991.
57. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, and Sollott SJ. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84: 1020-1031, 1999.
58. ATP channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol Heart Circ Physiol 280: H246-H255, 2001.
59. Weiland U, Haendeler J, Ihling C, Albus U, Scholz W, Ruetten H, Zeiher AM, and Dimmeler S. Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cardiovasc Res 45: 671-678, 2000.
60. Wilde AA, Escande D, Schumacher CA, Thuringer D, Mestre M, Fiolet JW, and Janse MJ. Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel. Circ Res 67: 835-843, 1990.
61. Wu B, Iwakiri R, Tsunada S, Utsumi H, Kojima M, Fujise T, Ootani A, and Fujimoto K. iNOS enhances rat intestinal apoptosis after ischemia-reperfusion. Free Radic Biol Med 33: 649-658, 2002.
62. + currents in pancreatic β-cells. Naunyn Schmiedebergs Arch Pharmacol 337: 225-230, 1988.